Novel APOB missense variants, A224T and V925L, in a black South African woman with marked hypocholesterolemia

•Two novel APOB variants were found in a South African female with hypolipidemia.•She was also homozygous for the APOE ε2 allele.•ApoB Ala224Thr was found in southern Africans but was not associated with lipids.•ApoB Val925Leu does not affect apoB secretion or interaction with MTP.•Her hypolipidemia may be a result of APOE 2/2 with a low baseline cholesterol.

BackgroundOne genetic cause of markedly low plasma concentrations of apolipoprotein (apo) B and low density lipoprotein (LDL)-cholesterol is familial hypobetalipoproteinemia.ObjectiveWe aimed to determine the molecular basis for the marked hypocholesterolemia consistent with heterozygous familial hypobetalipoproteinemia in a black female subject of Xhosa lineage.MethodsCoding regions of APOB, MTTP, PCSK9, ANGPTL3, SAR1B and APOC3 were sequenced, and APOE was genotyped. COS-7 cells were transfected with plasmids containing apoB variants. Western blotting was used to detect cellular and secreted apoB, and co-immunoprecipitation performed to assess binding with the microsomal triglyceride transfer protein (MTP).ResultsSequence analysis of the APOB gene revealed her to be heterozygous for two novel variants, c.751G>A (A224T) and c.2854G>C (V925L). She was also homozygous for the APOE ε2 allele, and did not carry a PCSK9 loss-of-function mutation. Although Ala224 is within the postulated MTP binding region in apoB, it is not conserved among mammalian species. Subsequent genotyping showed that Ala224Thr is found in a southern African population (n=654) with an allele frequency of 1.15% and is not associated with plasma lipid levels. Val925, like Ala224, is within the N-terminal 1000 amino acids required for lipoprotein assembly, but was not found in the population screen. However, in vitro studies showed that apoB V925L did not affect apoB48 production or secretion nor have a deleterious effect on MTP interaction with apoB.ConclusionTaken together, this suggests that the hypocholesterolemia in our case may be a result of being homozygous for APOE ε2 with a low baseline cholesterol.